Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy - 04/09/15

| This study was supported by the PhD program IAI DK W1212 and projects F4605 and F4613 of the Austrian Science Fund (Fonds zur Förderung der wissenschaftlichen Forschung) as well as by a research grant from Thermo Fisher, Uppsala, Sweden. |
|
| Disclosure of potential conflict of interest: C. Lupinek has received lecture fees from Thermo Fisher. M. Kundi has received consultancy fees from Baxter, Novartis, and Pfizer; has provided expert testimony for Ashcraft & Gerel, LLP; has been supported by the FP7 EU Project; and has received lecture fees from the Pediatric Society. R. Selb has received research support from Fonds zur Förderung der wissenschaftlichen Forschung (Austrian Science Fund). V. Niederberger has received research support from Fonds zur Förderung der wissenschaftlichen Forschung (grant nos. SFB4613 and MCCA). R. Valenta has received research support and payment for the development of educational presentations from Thermo Fisher and has received consultancy fees from Thermo Fisher and Fresenius Medical Care. E. Wollmann declares that she has no relevant conflicts of interest. |
Vol 136 - N° 3
P. 806 - septembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
